CRISPR Gene Therapy Patents: The Legal Battle Reshaping Biotechnology
The ongoing patent disputes surrounding CRISPR gene editing technology have profound implications for biotech innovation, patient access, and IP strategy.
Prof. James K. Chen
503 views